Journal of Gynecologic Oncology

Article	Citations
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?	198
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer	53
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use	45
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	35
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies	28
Developing standardized informed consent for hysterectomy and vulva cancer surgery	28
One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins	21
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	21
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	20
Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment	19
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	19
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II t	17
Development of an homologous recombination deficiency scoring algorithm for unmatched ovarian tumor sample based on next-generation sequencing	17
Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS	17
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial	17
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors	16
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	16
Adjuvant treatment algorithm based on recent ESGO/ESTRO/ESP guidelines for early endometrial carcinoma according to prognostic risk groups	16
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study	16
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement	16
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	16
Comparison of clinical outcomes between early and delayed diagnosis of cervical cancer following abnormal Pap smear results: a population-based cohort study using National Health Insurance data in Sou	16
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)	15
Impact of the diagnosis-surgery interval on survival outcomes and development of a nomogram for predicting survival in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results databa	15
Functions, interactions and prognostic role of POLE: a bioinformatics analysis	15

Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses	14
Is restaging surgery quintessential in suspected early-stage epithelial ovarian cancer? An ancillary study of the Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3002)	14
Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study	14
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	14
Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology	14
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome	13
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	13
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer	13
Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study	13
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective	12
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma	12
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis	12
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	12
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study	12
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer	12
Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program	12
Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification	12
Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group	11
Genotype distribution and risk factors for human papillomavirus infection	11
A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (PROVIDENCE trial)	11
Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer	11
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	11
Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: a systematic review and single-arm meta-analysis	11
Prognostic significance of psoas muscle index at diagnosis in cervical cancer progression	10
Noninvasive early warning markers for ovarian cancer: a Mendelian randomization study	10
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer	10
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	10
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis	10
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer	9
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study	9
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan	9
Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma	9
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis	9
Navigating the future of fertility preservation: advanced predictive strategies for treatment outcomes of endometrial atypical hyperplasia and carcinoma	9
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy	9
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients	9
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancer	9
Validation of molecular classification on diagnostic biopsy in endometrial carcinoma: the first step for a tailored approach	9
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy	9
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	9
Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lym	9
Identification of the prognostic immune subtype in copy-number high endometrial cancer	9
LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1	8
Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk	8
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”	8
Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution	8
The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study	8
RAIDS atlas of significant genetic and protein biomarkers in cervical cancer	8
Postoperative radiation therapy in women with FIGO stage I clear cell and papillary serous carcinomas of the uterus: an analysis of the SEER database	8
The necessity of adjuvant surgery for patients with high-risk chemorefractory or relapsed gestational choriocarcinoma with complete remission after anti-PD-1 therapy	8

Reviewer recognition in 2024	8
Laparoscopy-assisted laterally extended endopelvic resection and sacrectomy (beyond laterally extended endopelvic resection) for platinum-sensitive recurrent ovarian cancer	8
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance	8
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma	8
Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia	7
Evolving standards and future directions for systemic therapies in cervical cancer	7
Response to Corcept’s retraction request on manuscript of “Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study”	7
Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study	7
Clinical application value of the updated FIGO 2023 classification compared with FIGO 2009 for endometrial cancer staging in a Chinese cohort	7
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)	7
Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial	7
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial h	7
Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis	7
Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021	7
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	7
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening	7
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study	6
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia	6
Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data	6
Treatment patterns and prognosis of vulvar cancer: a nationwide retrospective analysis from the JSOG tumor registry (2016–2020)	6
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	6
PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan	6
The SHAPE trial: is good is good enough?	6
Sentinel node mapping in endometrial cancer	6
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma	6
Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer	6
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines	6
Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis	6
Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis	6
Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis	6
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis	6
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	6
Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries	6
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation	6
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study	5
Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer	5
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer	5
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	5
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	5
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma	5
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial	5
Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China	5
Comprehensive assessment of incidence, mortality, and lifetime risk of ovarian cancer: a global study with forecasts to 2050	5
External validation of the SUCCOR Risk score for predicting recurrence in early-stage cervical cancer patients treated with radical hysterectomy	5
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	5
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy	5
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins	5
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer	5
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023	5
Targeting BRAF pathway in low-grade serous ovarian cancer	5
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	5
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer	5
Revisiting the meaning of Trousseau sign and syndrome	5
Timing of adjuvant radiotherapy for early-stage endometrial carcinoma: a single-center retrospective cohort study	5
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications	5
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis	5
Long-term chemotherapy-induced peripheral neuropathy evaluated using patient-reported outcomes in gynecologic malignancies	4
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer	4
Clinical trial comparing the use of Orcellex® Brush versus Cervex-Brush® on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer	4
Trends in the cost of ovarian cancer across phases of care and surgical years in Korea	4
Modified posterior pelvic exenteration combined with ileocecal resection for locally advanced endometrial cancer	4
HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010–2021): a retrospective study	4
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	4
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor	4
An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer	4
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)	4
Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards models	4
Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis	4
Reevaluating the vesicouterine pouch: histological evidence for optimal dissection planes in oncologic surgery	4
Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3	4
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia	4
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study	4
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a r	4
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial	4
The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations	4
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway	4
FIGO staging of endometrial cancer: 2023	4
Prognostic factors and optimal management approaches for stage IB uterine leiomyosarcoma: a retrospective analysis	4
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan	3
Isolated para-aortic lymph node metastasis in endometrial cancer: clinical characteristics and survival analysis from a single-center cohort	3

HIPEC in recurrent ovarian cancer: flogging a tired HORSE?	3
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines	3
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec	3
The prognosis impact of NACT-IDS and PDS in advanced ovarian cancer: a systematic review and meta-analysis	3
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome	3
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	3
Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study	3
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	3
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer	3
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting	3
Letter to editor regarding the published manuscript: “A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer”	3
Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study	3
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer	3
Nodal surgery in early-stage cervical cancer: the PHENIX trial and the road ahead	3
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study	3
Expert commentary on HORSE/MITO18 and CHIPOR	3
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas	3
Clinical and prognostic insights into Trousseau’s syndrome in gynecologic malignancies: a multicenter study	3
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	3
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients	3
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma	3
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study	3
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential	3
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	3
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience	3
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study	3
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	3
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study	3
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.	3
Genetic analysis of cervical cancer with lymph node metastasis	3
Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis	3
FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2	3
Role of adjuvant chemotherapy in stage IC ovarian granulosa cell tumors: a systematic review and meta-analysis	3
Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis	3
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis	3
Impact of prior olaparib use on subsequent platinum-based therapy in recurrent ovarian cancer	3
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis	3
Reviewer recognition in 2022	3
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement	3
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan	3
Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients	2
Examining the relationship between cesarean section scar and endometrial cancer	2
Epidemiologic characteristics and a prognostic nomogram for patients with vulvar cancer: results from the Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1975 to 2016	2
Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years	2
Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm	2
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?	2
Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023	2
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin	2
Planning and performing simultaneous bariatric surgery and robotic hysterectomy in a super-obese patient with endometrial cancer	2
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomiz	2
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling	2
Is chemo-immunotherapy really beneficial for platinum-resistant ovarian cancer?	2
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients	2
Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer	2
Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches	2
Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center	2
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy	2
Relationship between the lateral dissection lines of various radical hysterectomies and anatomical structures in the female pelvis: an educational video from the Sapporo Cadaver Surgical Workshop	2
ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis	2
Association between resection margin and local recurrence in the treatment of primary squamous cell vulvar carcinoma	2
Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study	2
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCR	2
Evaluation of HER2 status in endometrial carcinoma using endometrial, gastric, and breast cancer criteria: focus on HER2-low	2
Effect of quality control program on surgical management in advanced ovarian cancer	2
Radiotherapy patterns of care for recurrent ovarian cancer by gynecologic and radiation oncologists: a Korean Gynecologic Oncology Group study (KGOG-3064S1)	2
Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic	2
The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation	2
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes	2
UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2	2
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer	2
Quality indicators for endometrial cancer care in Japan	2
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study	2
The triglyceride-glucose index as a measure of insulin resistance and risk of incident endometrial cancer: a prospective analysis in UK Biobank	2
Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease	2
Global burden of uterine cancer in 204 countries and territories and its predicted level in 15 years, from 1990 to 2021	2
Retraction: Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	2
Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma	2
Application value of personalized 3D printing vaginal model for the Image-guided adaptive brachytherapy of cervical cancer	2
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma	2
Evaluation of autophagy related ATG4B gene, protein and miR-655-3p expression levels in endometrial cancer and hyperplasia	2